Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1980-03-26
1981-11-03
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Lymphokine
A61K 39005
Patent
active
042985960
ABSTRACT:
A novel, glycoprotein antigen obtained from T. cruzi organisms can be used in vaccines for inducing immunity in humans to Chagas' disease. The glycoprotein is extracted by treating trypanosomes with a detergent and separating it from the cell debris and other proteinaceous material by affinity chromatography using lectin with affinity for glucose, mannose or galactose.
REFERENCES:
Guimaraes et al., Rev. Inst. Med. Trop. Sao Paulo 16(4), 182-188, 1974.
Njogu and Humphryes, Exp. Parasitology 31, 178-187 (1972).
Johnson et al., Nature Oct. 5, 1963, p. 83 Protective Effect of Killed Tryanosome Vaccines with Incorporated Adjuvants.
Williams, A. F., Biochemical Society Transactions, 1976, vol 4, 1-4.
G.A.M. Cross, Am. Jou. Trop. Med. Hyg. 1977, 26(6), 240-244.
Chem. Abstr. 92:142562h 108937z 107010e (1980) 9:37290z 2327q 90:150117R 134961F (1979) 85:43515u (1976) 84:87800s (1976) 83:24799g (1975) 82:29520y (1975) 76: 138895w (1972).
K. Vickerman, Ciba Foundation Symposium No. 24, 1974, 53-80.
G.A.M. Cross, Parasitology, 1975, 71, 393-417.
Snary et al. Febs Letters Apr. 1979, pp. 166-170 Elsevier/North-Holland Biomedical Press.
Scott et al., Nature, vol. 282-No. 5734, pp. 73-74 Nov. 1, 1979.
Alves et al., Rev. Inst. Med. Trop. Sao Paulo, 20(4), pp. 246-247, 1978.
Bergendi et al., Experimental Parasitology, 28, 258-262 (1970).
Gottlieb, M., Journal of Immunology, vol. 119 No. 2, 465-470, Aug. 1977.
Snary et al., Anal. Biochemistry, 74, 457-465 (1976).
Cross, G.A.M., Nature, vol. 277 (Jan. 25, 1979) No. 5694, 310-312.
Bone and Parent, J. Gen. Microbiol. (1963), 31, 261-268.
Teixeira et al., Am. J. of Pathology (1975) 80,(1), 163-180.
Cappa et al., J. Parasitology (1976) vol. 62, No. 1, 130-131.
Segura et al., J. Parasitology (1976) vol. 62, No. 1, 131-133.
Goble et al., Parasitology (1964) 50, Suppl. 19.
Johnson et al., Nature (1963) No. 4901, 83.
Segura et al., J. Protozool (1974) 21 (4), 571-574.
Cross, G.A.M., Proc. R. Soc Lond. B, 202, 52-72 (1978).
Seneca et al., Nature, vol. 209, No. 5020, 309-310, Jan. 15, 1966.
Laemmli, Nature, vol. 227, 680-685, Aug. 15, 1970.
Alves and Colli, J. Protozool, 21 (4), 573-578 (1974).
Gutterridge et al., J. Protozool, 16 (3), 521-575 (1969).
Alves et al., Febs Letters, 99(1) 81-85, Mar. 1979.
Silveira et al., Biochimica et Biophysica Acta, 550 (1979) 222-232.
Cross, G.A.M., J. Gen. Micro Biology (1979), 113, 1-11.
Allsopp and Njogu, Trans. R. Sci. Trop. Med. 1972, 66, 347-348.
Alves and Colli, Febs Letters, vol. 52, No. 2, 188-190, Apr. 1975.
De Lederkremer et al., Biochimica et Biophysica Acta, 444, (1976), 85-96.
De Lederkremer et al., Eur. J. Biochem., 74, 263-267 (1977).
Goncalves and Yamaha, J. Trop. Med. Hys. 1969, 72, 39-44.
Stohlman et al., Arch. Mikrobiol. 92, 301-311 (1973).
Hayman and Crumpton, Biochem. and Biophys. Res. Communications, vol. 47, No. 4 923-930 (1972).
Fernandes and Caceres, Rev. Inst. Med. Trop., Sao Paulo, 18, 130-131, 1976.
Brown Donald
Burroughs Wellcome Co.
Rose Shep K.
LandOfFree
Trypanosoma cruzi glycoprotein vaccine for inducing immunity to does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Trypanosoma cruzi glycoprotein vaccine for inducing immunity to , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trypanosoma cruzi glycoprotein vaccine for inducing immunity to will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1064399